{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:44:44Z","timestamp":1787762684534,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Technology and Innovation Commission of Shenzhen Municipality","award":["JCY20220530142010023"],"award-info":[{"award-number":["JCY20220530142010023"]}]},{"name":"Nanshan District Health System Science and Technology Major Project","award":["NSZD2023055"],"award-info":[{"award-number":["NSZD2023055"]}]},{"name":"Scientific research project of Huazhong University of Science and Technology Union Shenzhen Hospital","award":["YN2021009"],"award-info":[{"award-number":["YN2021009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01794-3","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:51:55Z","timestamp":1749545515000},"page":"4667-4678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bladder Cancer Growth is Inhibited by Upregulating CircFUT8 through the METTL14\/FMR1 Signaling Pathway"],"prefix":"10.1007","volume":"83","author":[{"given":"Weifeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"1794_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017). Bladder cancer incidence and mortality: A global overview and recent trends. European Urology, 71, 96\u2013108.","journal-title":"European Urology"},{"key":"1794_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1794_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bioactmat.2023.08.013","volume":"31","author":"J Liu","year":"2024","unstructured":"Liu, J., Yang, T. Y., Dai, L. Q., Shi, K., Hao, Y., Chu, B. Y., Hu, D. R., Bei, Z. W., Yuan, L. P., Pan, M., & Qian, Z. Y. (2024). Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer. Bioactive Materials, 31, 315\u2013332.","journal-title":"Bioactive Materials"},{"key":"1794_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A., Bruins, H. M., Cathomas, R., Comp\u00e9rat, E. M., Cowan, N. C., Gakis, G., Hern\u00e1ndez, V., Linares Espin\u00f3s, E., Lorch, A., Neuzillet, Y., Rouanne, M., Thalmann, G. N., Veskim\u00e4e, E., Ribal, M. J., & van der Heijden, A. G. (2021). European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. European Urology, 79, 82\u2013104.","journal-title":"European Urology"},{"key":"1794_CR5","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmstr\u00f6m, P. U., Choi, W., Guo, C. C., Lotan, Y., & Kassouf, W. (2016). Bladder cancer. Lancet, 388, 2796\u20132810.","journal-title":"Lancet"},{"key":"1794_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han, J., Wang, J. Z., Yang, X., Yu, H., Zhou, R., Lu, H. C., Yuan, W. B., Lu, J. C., Zhou, Z. J., Lu, Q., Wei, J. F., & Yang, H. (2019). METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Molecular Cancer, 18, 110.","journal-title":"Molecular Cancer"},{"key":"1794_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-022-02462-7","volume":"41","author":"L Liang","year":"2022","unstructured":"Liang, L., Zhu, Y., Li, J., Zeng, J., & Wu, L. (2022). ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. Journal of Experimental and Clinical Cancer Research, 41, 261.","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"1794_CR8","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-21-1518","volume":"81","author":"W Wei","year":"2021","unstructured":"Wei, W., Sun, J., Zhang, H., Xiao, X., Huang, C., Wang, L., Zhong, H., Jiang, Y., Zhang, X., & Jiang, G. (2021). Circ0008399 interaction with WTAP promotes assembly and activity of the m(6)A methyltransferase complex and promotes cisplatin resistance in bladder cancer. Cancer Research, 81, 6142\u20136156.","journal-title":"Cancer Research"},{"key":"1794_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An, Y., & Duan, H. (2022). The role of m6A RNA methylation in cancer metabolism. Molecular Cancer, 21, 14.","journal-title":"Molecular Cancer"},{"key":"1794_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fbioe.2018.00089","volume":"6","author":"ZX Liu","year":"2018","unstructured":"Liu, Z. X., Li, L. M., Sun, H. L., & Liu, S. M. (2018). Link between m6A modification and cancers. Frontiers in Bioengineering and Biotechnology, 6, 89.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"1794_CR11","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","volume":"38","author":"M Cheng","year":"2019","unstructured":"Cheng, M., Sheng, L., Gao, Q., Xiong, Q., Zhang, H., Wu, M., Liang, Y., Zhu, F., Zhang, Y., Zhang, X., Yuan, Q., & Li, Y. (2019). The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network. Oncogene, 38, 3667\u20133680.","journal-title":"Oncogene"},{"key":"1794_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02044-3","volume":"23","author":"L Min","year":"2022","unstructured":"Min, L., Shu-Li, Z., Feng, Y., Han, H., Shao-Jun, L., Sheng-Xiong, T., Jia-Yu, T., Xiang-Zhi, F., & Dan, F. (2022). NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial-mesenchymal transition. Respiratory Research, 23, 128.","journal-title":"Respiratory Research"},{"key":"1794_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01771-5","volume":"22","author":"T Li","year":"2023","unstructured":"Li, T., Gu, Y., Xu, B., Kuca, K., Zhang, J., & Wu, W. (2023). CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure. Molecular Cancer, 22, 77.","journal-title":"Molecular Cancer"},{"key":"1794_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0892-z","volume":"17","author":"F Xie","year":"2018","unstructured":"Xie, F., Li, Y., Wang, M., Huang, C., Tao, D., Zheng, F., Zhang, H., Zeng, F., Xiao, X., & Jiang, G. (2018). Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p\/p27 axis. Molecular Cancer, 17, 144.","journal-title":"Molecular Cancer"},{"key":"1794_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0908-8","volume":"17","author":"H Liu","year":"2018","unstructured":"Liu, H., Bi, J., Dong, W., Yang, M., Shi, J., Jiang, N., Lin, T., & Huang, J. (2018). Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p\/G3BP2\/SRC\/FAK axis. Molecular Cancer, 17, 161.","journal-title":"Molecular Cancer"},{"key":"1794_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21655979.2019.1586056","volume":"10","author":"F Gao","year":"2019","unstructured":"Gao, F., Wu, H., Wang, R., Guo, Y., Zhang, Z., Wang, T., Zhang, G., Liu, C., & Liu, J. (2019). MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered, 10, 1\u201312.","journal-title":"Bioengineered"},{"key":"1794_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep25677","volume":"6","author":"S Zou","year":"2016","unstructured":"Zou, S., Toh, J. D. W., Wong, K. H. Q., Gao, Y. G., Hong, W., & Woon, E. (2016). N(6)-Methyladenosine: A conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5. Scientific Reports, 6, 25677.","journal-title":"Scientific Reports"},{"key":"1794_CR18","first-page":"1631","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu, S., Zhuo, L., Wang, J., Zhang, Q., Li, Q., Li, G., Yan, L., Jin, T., Pan, T., Sui, X., Lv, Q., & Xie, T. (2020). METTL3 plays multiple functions in biological processes. American Journal of Cancer Research, 10, 1631\u20131646.","journal-title":"American Journal of Cancer Research"},{"key":"1794_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., Dai, Q., Chen, W., & He, C. (2014). A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nature Chemical Biology, 10, 93\u201395.","journal-title":"Nature Chemical Biology"},{"key":"1794_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1084-1","volume":"18","author":"C Gu","year":"2019","unstructured":"Gu, C., Wang, Z., Zhou, N., Li, G., Kou, Y., Luo, Y., Wang, Y., Yang, J., & Tian, F. (2019). Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1. Molecular Cancer, 18, 168.","journal-title":"Molecular Cancer"},{"key":"1794_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.canlet.2021.07.041","volume":"520","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Hua, X., Tu, H., Li, J., Zhang, Z., & Max, C. (2021). Isorhapontigenin (ISO) inhibits EMT through FOXO3A\/METTL14\/VIMENTIN pathway in bladder cancer cells. Cancer Letters, 520, 400\u2013408.","journal-title":"Cancer Letters"},{"key":"1794_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s11658-022-00406-9","volume":"27","author":"L Wang","year":"2022","unstructured":"Wang, L., Yi, X., Xiao, X., Zheng, Q., Ma, L., & Li, B. (2022). Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression. Cellular and Molecular Biology Letters, 27, 106.","journal-title":"Cellular and Molecular Biology Letters"},{"key":"1794_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.omto.2019.12.014","volume":"16","author":"Q He","year":"2020","unstructured":"He, Q., Yan, D., Dong, W., Bi, J., Huang, L., Yang, M., Huang, J., Qin, H., & Lin, T. (2020). circRNA circFUT8 upregulates kr\u00fcpple-like factor 10 to inhibit the metastasis of bladder cancer via sponging miR-570-3p. Molecular Therapy Oncolytics, 16, 172\u2013187.","journal-title":"Molecular Therapy Oncolytics"},{"key":"1794_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-021-02175-3","volume":"41","author":"F Qiu","year":"2022","unstructured":"Qiu, F., Liu, Q., Xia, Y., Jin, H., Lin, Y., & Zhao, X. (2022). Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation. Journal of Experimental and Clinical Cancer Research, 41, 22.","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"1794_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., Hu, Y. C., H\u00fcttelmaier, S., Skibbe, J. R., Su, R., Deng, X., Dong, L., Sun, M., Li, C., Nachtergaele, S., Wang, Y. et al. (2018). Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nature Cell Biology, 20, 285\u2013295.","journal-title":"Nature Cell Biology"},{"key":"1794_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/ph14070618","volume":"14","author":"M Stella","year":"2021","unstructured":"Stella, M., Falzone, L., Caponnetto, A., Gattuso, G., Barbagallo, C., Battaglia, R., Mirabella, F., Broggi, G., Altieri, R., Certo, F., Caltabiano, R., Barbagallo, G., Musumeci, P., Ragusa, M., Pietro, C. D., Libra, M., Purrello, M., & Barbagallo, D. (2021). Serum extracellular vesicle-derived circHIPK3 and circSMARCA5 are two novel diagnostic biomarkers for glioblastoma multiforme. Pharmaceuticals, 14, 618.","journal-title":"Pharmaceuticals"},{"key":"1794_CR27","doi-asserted-by":"publisher","first-page":"649383","DOI":"10.3389\/fmed.2021.649383","volume":"8","author":"M Wang","year":"2021","unstructured":"Wang, M., Xie, F., Lin, J., Zhao, Y., Zhang, Q., Liao, Z., & Wei, P. (2021). Diagnostic and prognostic value of circulating circRNAs in cancer. Frontiers in Medicine, 8, 649383.","journal-title":"Frontiers in Medicine"},{"key":"1794_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-021-01894-x","volume":"40","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Liu, K., Cui, J., Xiong, J., Wu, H., Peng, T., & Guo, Y. (2021). Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p\/GOT1 axis in pancreatic cancer. Journal of Experimental and Clinical Cancer Research, 40, 124.","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"1794_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12651-2","volume":"10","author":"RX Chen","year":"2019","unstructured":"Chen, R. X., Chen, X., Xia, L. P., Zhang, J. X., Pan, Z. Z., Ma, X. D., Han, K., Chen, J. W., Judde, J. G., Deas, O., Wang, F., Ma, N. F., Guan, X., Yun, J. P., Wang, F. W., Xu, R. H., & Dan, X. (2019). N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nature Communications, 10, 4695.","journal-title":"Nature Communications"},{"key":"1794_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang, Y., Fan, X., Mao, M., Song, X., Wu, P., Zhang, Y., Jin, Y., Yang, Y., Chen, L. L., Wang, Y., Wong, C. C., Xiao, X., & Wang, Z. (2017). Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Research, 27, 626\u2013641.","journal-title":"Cell Research"},{"key":"1794_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du, A., Li, S., Zhou, Y., Disoma, C., Liao, Y., Zhang, Y., Chen, Z., Yang, Q., Liu, P., Liu, S., Dong, Z., Razzaq, A., Tao, S., Chen, X., Liu, Y., Xu, L., Zhang, Q., Li, S., Peng, J., & Xia, Z. (2022). M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Molecular Cancer, 21, 109.","journal-title":"Molecular Cancer"},{"key":"1794_CR32","first-page":"677","volume":"8","author":"P Yu","year":"2023","unstructured":"Yu, P., Wang, J., Xu, G. E., Zhao, X., Cui, X., Feng, J., Sun, J., Wang, T., Spanos, M., Lehmann, H. I., Li, G., Xu, J., Wang, L., & Xiao, J. (2023). RNA m(6)A-Regulated circ-ZNF609 suppression ameliorates doxorubicin-induced cardiotoxicity by upregulating FTO. JACC: Basic to Translational Science, 8, 677\u2013698.","journal-title":"JACC: Basic to Translational Science"},{"key":"1794_CR33","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.7150\/thno.71456","volume":"12","author":"P Liu","year":"2022","unstructured":"Liu, P., Fan, B., Othmane, B., Hu, J., Li, H., Cui, Y., Ou, Z., Chen, J., & Zu, X. (2022). m(6)A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism. Theranostics, 12, 6291\u20136307.","journal-title":"Theranostics"},{"key":"1794_CR34","doi-asserted-by":"publisher","first-page":"e1010366","DOI":"10.1371\/journal.pgen.1010366","volume":"18","author":"J Huang","year":"2022","unstructured":"Huang, J., Zhou, W., Hao, C., He, Q., & Tu, X. (2022). The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer. PLoS Genetics, 18, e1010366.","journal-title":"PLoS Genetics"},{"key":"1794_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","volume":"22","author":"JD Richter","year":"2021","unstructured":"Richter, J. D., & Zhao, X. (2021). The molecular biology of FMRP: New insights into fragile X syndrome. Nature Reviews Neuroscience, 22, 209\u2013222.","journal-title":"Nature Reviews Neuroscience"},{"key":"1794_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05391-7","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu, Y., Gao, Q., Ma, S., Yu, P., Ding, S., Yao, X., Zhang, Z., Lu, S., Lu, M., Zhang, J., Wang, Y., Qian, X., & Zhong, J. (2022). FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m(6)A-dependent manner. Cell Death and Disease, 13, 941.","journal-title":"Cell Death and Disease"},{"key":"1794_CR37","first-page":"5399","volume":"15","author":"Y Nianyong","year":"2023","unstructured":"Nianyong, Y., & Li, G. (2023). Comprehensive analysis reveals the involvement of hsa_circ_0037858\/miR-5000-3p\/FMR1 axis in malignant metastasis of clear cell renal cell carcinoma. Aging, 15, 5399\u20135411.","journal-title":"Aging"},{"key":"1794_CR38","doi-asserted-by":"publisher","first-page":"1014861","DOI":"10.3389\/fimmu.2022.1014861","volume":"13","author":"J Kong","year":"2022","unstructured":"Kong, J., Lu, S., Zhang, L., Yao, Y., Zhang, J., Shen, Z., Luo, M., Liu, B., Zheng, J., & Lin, T. (2022). m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent. Frontiers in Immunology, 13, 1014861.","journal-title":"Frontiers in Immunology"},{"key":"1794_CR39","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li, L. T., Jiang, G., Chen, Q., & Zheng, J. N. (2015). Ki67 is a promising molecular target in the diagnosis of cancer (review). Molecular Medicine Reports, 11, 1566\u20131572.","journal-title":"Molecular Medicine Reports"},{"key":"1794_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi, Z. D., Hao, L., Han, X. X., Wu, Z. X., Pang, K., Dong, Y., Qin, J. X., Wang, G. Y., Zhang, X. M., Xia, T., Liang, Q., Zhao, Y., Li, R., Zhang, S. Q., Zhang, J. H., Chen, J. G., Wang, G. C., Chen, Z. S., & Han, C. H. (2022). Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Molecular Cancer, 21, 37.","journal-title":"Molecular Cancer"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01794-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:51:53Z","timestamp":1764910313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01794-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01794-3","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"28 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by Ethics Committee of Qianhai Shekou Free Trade Zone Hospital (2023KY-004-01K). All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from each patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}